Aptus Pharma Ltd

Fri 18/09/2026,16:1:0 | BSE : APPL

₹353.406.90 (1.99%)

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

Open

₹ 353.40

Previous Close

₹ 346.50

Volume

8400

Mkt Cap ( ₹ Cr)

₹ 606.08

High

₹ 353.40

Low

₹ 352.90

52 Week High

₹ 360.60

52 Week Low

₹ 32.32

Book Value Per Share

₹ 13.61

Dividend Yield

₹ 0.00

Face Value

₹₹10.00

What's Your Call?

Collective community sentiment on Aptus Pharma Ltd

Your Vote -

Buy

60.00%

Hold

20.00%

Sell

20.00%

60.00%

5 users have voted

No Records Found

Option Chain

Analyzes market sentiment, predicts Aptus Pharma Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Aptus Pharma - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    17 Sep 2026, 2:36PM Intimation of Investor Meeting/Interaction
  • Aptus Pharma - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    14 Sep 2026, 8:26PM Scrutinizer's Report on remote E-Voting
  • Aptus Pharma - Shareholder Meeting / Postal Ballot-Outcome of AGM

    14 Sep 2026, 7:40PM Summary of proceedings of the 16th Annual General Meeting of the Company held on 14th September, 2026
  • Aptus Pharma - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    14 Sep 2026, 8:26PM Scrutinizer's Report on remote E-Voting
  • Aptus Pharma - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    14 Sep 2026, 8:26PM Scrutinizer's Report on remote E-Voting
  • Aptus Pharma - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    14 Sep 2026, 8:26PM Scrutinizer's Report on remote E-Voting
  • Aptus Pharma - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    14 Sep 2026, 8:26PM Scrutinizer's Report on remote E-Voting
  • Aptus Pharma - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    14 Sep 2026, 8:26PM Scrutinizer's Report on remote E-Voting
  • Aptus Pharma - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    14 Sep 2026, 8:26PM Scrutinizer's Report on remote E-Voting
  • Aptus Pharma - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    14 Sep 2026, 8:26PM Scrutinizer's Report on remote E-Voting
  • Aptus Pharma - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    12 Sep 2026, 1:33PM Intimation of Investor meeting / interaction
  • Aptus Pharma - CORRIGENDUM / ADDENDUM TO NOTICE OF ANNUAL GENERAL MEETING AND E-VOTING

    7 Sep 2026, 8:13PM CORRIGENDUM / ADDENDUM TO NOTICE OF ANNUAL GENERAL MEETING AND E-VOTING
  • Aptus Pharma - Announcement under Regulation 30 (LODR)-Press Release / Media Release

    24 Aug 2026, 1:35PM Aptus Pharma Limited - Press release regarding - Aptus Pharma Limited charts next growth phase with focus on manufacturing, pan-India expansion and gl
  • Aptus Pharma - Announcement under Regulation 30 (LODR)-Investor Presentation

    21 Aug 2026, 7:47PM Intimation of investor presentation under regulation 30 of SEBI (LODR) Regulations, 2015
  • Aptus Pharma - Reg. 34 (1) Annual Report.

    21 Aug 2026, 7:37PM SUB: Submission of Annual Report for the FY 2025-26 comprising of the Notice of Annual General Meeting, Directors Report, Independent Auditors Report
  • Aptus Pharma - NOTICE OF ANNUAL GENERAL MEETING AND E-VOTING

    21 Aug 2026, 7:26PM Notice is hereby given that the Annual General Meeting of the Company will be held on Monday 14th September, 2026, Through Video Conferencing (VC)/ Ot
  • Aptus Pharma - Board Meeting Outcome for Outcome Of Board Meeting Dated 17.08.2026

    17 Aug 2026, 6:07PM Outcome of Board Meeting dated 17.08.2026
  • Aptus Pharma - Board Meeting Intimation for Prior Intimation Of Board Meeting To Be Held On Monday, August 17, 2026

    12 Aug 2026, 5:55PM Aptus Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 17/08/2026 ,inter alia, to consider and app
  • Aptus Pharma - Clarification Letter In Respect Of Outcome Of Board Meeting Held On 08.08.2026

    10 Aug 2026, 2:39PM Please find attached Clarification letter in respect of Outcome of Board meeting held on 08.08.2026 and submitted on 08.08.2026 for approval of Prefer
  • Aptus Pharma - Board Meeting Outcome for Outcome Of Board Meeting For Approval Of Preferential Issue Of Shares

    8 Aug 2026, 5:28PM please find attached outcome of board meeting dated 08.08.2026 for approval of preferential issue of shares
  • Aptus Pharma - Board Meeting Intimation for Intimation Of Board Meeting To Be Held On Saturday, August 8, 2026

    5 Aug 2026, 6:43PM Aptus Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/08/2026 ,inter alia, to consider and app
  • Aptus Pharma has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2026

    18 Jul 2026, 7:20PM As of June 2026, 72.89% is owned by Indian Promoters and 27.11% by Public. <p align=justify> Top five Promoters holding highest number of shares of Ap
  • Aptus Pharma - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    18 Jul 2026, 1:15PM Compliance Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
  • Aptus Pharma - Announcement under Regulation 30 (LODR)-Credit Rating

    27 Jun 2026, 1:41PM Intimation Regarding Credit Rating assigned by CARE Ratings under Reluation 30 of SEBI (LODR) Regulations, 2015.

Key fundamentals

Evaluate the intrinsic value of Aptus Pharma Ltd stock 

Name March-26 March-25 March-24
Assets 30.5278 17.3229 7.0746
Liabilities 30.5278 17.3229 7.0746
Equity 6.86 5 0.3
Gross Profit 7.4473 4.8479 1.5468
Net Profit 4.6199 3.0996 0.7982
Cash From Operating Activities -5.6027 -1.8382 -2.1746
NPM(%) 9.91 12.62 4.46
Revenue 46.5746 24.5577 17.857
Expenses 39.1273 19.7098 16.3102
ROE(%) 19.78 13.27 3.41

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day

Peers

Other companies within the same industry or sector that are comparable to Aptus Pharma Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Visagar Polytex Ltd 0.53 3.92 0.00 10142.09 -5.25 0.00
India Motor Parts and Accessories Ltd 1055.10 -1.47 13.66 432.43 773.64 3.08
Mihika Industries Ltd 11.69 1.39 146.13 346.50 0.86 0.00
Hathway Cable and Datacom Ltd 10.01 0.20 23.79 61333.96 23.25 0.00

Company Info

Our Company was originally incorporated as "Aptus Pharma Private Limited" as a private limited company under the provisions of the Companies Act, 1956 pursuant to a Certificate of Incorporation dated August 12, 2010, issued by the Registrar of Companies, Gujarat. Subsequently, our Company was converted into a public limited company in accordance with the provisions of the Companies Act, 2013, pursuant to a special resolution passed by the shareholders in their extraordinary general meeting held on November 30, 2024. A fresh Certificate of Incorporation consequent upon such conversion was issued by the Registrar of Companies, Central Processing Centre, on December 12, 2024, and the name of our Company was changed to "Aptus Pharma Limited." The Corporate Identification Number of our Company is U24230GJ2010PLC061957.MAJOR EVENTS:2010- Incorporation of our company under the name "Aptus Pharma Private Limited"2011-2013- Commenced operations through four regional headquarters in Gujarat. Launched a portfolio of 25 products targeting essential therapeutic segments.2013-2016- Achieved approximately 33% geographical coverage in Gujarat. Expanded product portfolio to over 50 products, catering to both acute and chronic segments.2016-2019- Increased portfolio to over 70 products in response to evolving therapeutic requirements.2019-2022- Extended presence to around 80% of Gujarat, including remote areas. Product portfolio grew to over 100 products. Appointed a C&F agent in Ahmedabad and improved logistics infrastructure.2022-2024- Achieved full geographical coverage across Gujarat. Expanded product portfolio to over 175 products. Established three operational divisions: Acute, Chronic, and OTC. Initiated in-house manufacturing under a loan license arrangement.2024- Converted to a public limited company and changed name to "Aptus Pharma Limited".2025-Aptus Pharma Launched a new product Shirovita Hair Oil (Ayurvedic Hair Oil).

Our Company was originally incorporated as "Aptus Pharma Private Limited" as a private limited company under the provisions of the Companies Act, 1956 pursuant to a Certificate of Incorporation dated August 12, 2010, issued by the Registrar of Companies, Gujarat. Subsequently, our Company was converted into a public limited company in accordance with the provisions of the Companies Act, 2013, pursuant to a special resolution passed by the shareholders in their extraordinary general meeting held on November 30, 2024. A fresh Certificate of Incorporation consequent upon such conversion was issued by the Registrar of Companies, Central Processing Centre, on December 12, 2024, and the name of our Company was changed to "Aptus Pharma Limited." The Corporate Identification Number of our Company is U24230GJ2010PLC061957.MAJOR EVENTS:2010- Incorporation of our company under the name "Aptus Pharma Private Limited"2011-2013- Commenced operations through four regional headquarters in Gujarat. Launched a portfolio of 25 products targeting essential therapeutic segments.2013-2016- Achieved approximately 33% geographical coverage in Gujarat. Expanded product portfolio to over 50 products, catering to both acute and chronic segments.2016-2019- Increased portfolio to over 70 products in response to evolving therapeutic requirements.2019-2022- Extended presence to around 80% of Gujarat, including remote areas. Product portfolio grew to over 100 products. Appointed a C&F agent in Ahmedabad and improved logistics infrastructure.2022-2024- Achieved full geographical coverage across Gujarat. Expanded product portfolio to over 175 products. Established three operational divisions: Acute, Chronic, and OTC. Initiated in-house manufacturing under a loan license arrangement.2024- Converted to a public limited company and changed name to "Aptus Pharma Limited".2025-Aptus Pharma Launched a new product Shirovita Hair Oil (Ayurvedic Hair Oil).

Parent Organisation

Aptus Pharma Ltd.

Founded

12/08/2010

Managing Director

Mr.Tejash M Hathi

NSE Symbol

FAQ